Most cases taken on a “if you don’t win, you don’t pay” basis.
Not all lawyers are willing to take your case.
Find out how to collect the most money for your injuries!
Fill out the form on the right to have a lawyer contact you.
For faster service call 800-611-7080
Choosing the right lawyer for your case can be a life changing decision.
Choosing the wrong lawyer for your case can cost you millions.
We match injured clients with law firms experienced in their case types.
Find out how to collect the most money for your injuries!
Fill out the form on the right and we will have an experienced lawyer contact you.
For faster service call 800-611-7080

Actos Lawyer

Actos Lawyer Contact Page

 

Actos Lawyer (10/6/11): An experienced Actos Lawyer can be your best asset if you have possibly suffered from taking Actos. Studies have linked the diabetes drug Actos to serious adverse effects from taking this medication.  An increased risk in bladder cancer with prolonged use of the medication has been associated with this drug. Actos (pioglitazone) is used for the treatment of individuals with Type 2 Diabetes for help in controlling blood sugar levels.  The U.S. Food and Drug Administration (FDA) issued a warning for diabetic patients taking Actos.  An Actos Lawyer has the knowledge and skill to represent individuals who have been injured while taking Actos.  An Actos Cancer Lawyer can advise you about any concerns you may have.  In addition, an Actos Cancer Lawyer can help you determine if you are entitled to obtaining compensation if you believe you developed bladder cancer from being prescribed the drug Actos.  If you or a loved one has suffered because of taking Actos, it is important to speak with an Actos Lawyer immediately.  Best Legal Source will help put you in touch with an Actos Lawyer.  Complete the form to the right or call the number listed below to contact Best Legal Source.

1-800-611-7080

 
If represented by a seasoned Actos Lawyer, you will benefit from the knowledge he or she may have regarding the Actos warnings.  The FDA has ordered that the patient Medication Guide for Actos be revised to include the information on the increased risk of bladder cancer after reviewing new information on the side effects of Actos.  Also, an epidemiological study conducted in France suggests an increased risk of Actos bladder cancer.  Based on the results of this study, France has suspended the use of pioglitazone and Germany has recommended not prescribing Actos to new patients due to the reported side effects.  If you are among Actos victims suffering because of taking this medication, please call us today. Best Legal Source will help put you in touch with an Actos Lawyer who can discuss your legal options.   Consider contacting an Actos Cancer Lawyer if you took Actos and developed the symptoms of bladder cancer. Please call our toll free number today. Time may be limited in your case.

Best Legal Source does not have any affiliation or connection with the makers of Actos.  Actos Lawyer is a general term used to describe the legal process and services provided by an attorney experienced in Actos lawsuits and similar cases.  The use of the terms Actos Lawyer, Actos Cancer Lawyer and any other phrases containing the word Actos does not imply any relationship between Best Legal Source and the makers of Actos.  Actos is a trademark of its maker, Takeda Pharmaceutical Company Limited, based in Japan.

Prolonged use of Actos is believed to be associated with bladder cancer. This is a potentially life threatening disease. If you believe you may have been hurt by taking the drug, you need to protect your rights.   Best Legal Source will help you speak to an experienced Actos Lawyer if you believe you or a loved one has suffered from the use of this drug.  Please contact Best Legal Source by calling the toll free number below.  You need the advice of a seasoned Actos Bladder Cancer lawyer. Allow Best Legal Source to help you get put in touch with one.  Call today.

1-800-611-7080

 

Posted in Actos Cancer Lawyer, Actos Lawyer | Tagged , | 1 Comment